Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect?

Bisphosphonates are recommended in the treatment of osteoporosis and some cancers, in which case they prevent the appearance of bone metastasis. The patients taking bisphosphonates are at increased risk of developing bisphosphonate-related osteonecrosis of jaw (BRONJ) which is characterised by the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Petcu, Eugen B, Ivanovski, Saso, Wright, Robert G, Slevin, Mark, Miroiu, Rodica I, Brinzaniuc, Klara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479027/
https://www.ncbi.nlm.nih.gov/pubmed/22770117
http://dx.doi.org/10.1186/1746-1596-7-78

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479027/
https://www.ncbi.nlm.nih.gov/pubmed/22770117
http://dx.doi.org/10.1186/1746-1596-7-78

Ejemplares similares